Prognostic significance of receptor expression discordance between primary and recurrent breast cancers: a meta-analysis

被引:0
|
作者
Sho Shiino
Graham Ball
Binafsha M. Syed
Sasagu Kurozumi
Andrew R. Green
Hitoshi Tsuda
Shin Takayama
Akihiko Suto
Emad A. Rakha
机构
[1] University of Nottingham,Division of Cancer and Stem Cells, School of Medicine
[2] National Cancer Center Hospital,Department of Breast Surgery
[3] John Van Geest Cancer Research Centre,School of Science & Technology
[4] Nottingham Trent University,Head of Clinical Research Division, Medical Research Centre
[5] Liaquat University of Medical & Health Sciences,Department of Breast Surgery
[6] International University of Health and Welfare,Department of General Surgical Science
[7] Gunma University Graduate School of Medicine,Department of Basic Pathology
[8] National Defense Medical College Hospital,Department of Histopathology
[9] Nottingham University Hospital NHS Trust,undefined
来源
Breast Cancer Research and Treatment | 2022年 / 191卷
关键词
Breast cancer; Receptor discordance; Estrogen receptor; Progesterone receptor; Human epidermal growth factor receptor 2; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 14
页数:13
相关论文
共 50 条
  • [1] Prognostic significance of receptor expression discordance between primary and recurrent breast cancers: a meta-analysis
    Shiino, Sho
    Ball, Graham
    Syed, Binafsha M.
    Kurozumi, Sasagu
    Green, Andrew R.
    Tsuda, Hitoshi
    Takayama, Shin
    Suto, Akihiko
    Rakha, Emad A.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (01) : 1 - 14
  • [2] Prognostic implications of receptor discordance between primary and recurrent breast cancer
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Murata, Takeshi
    Seki, Tomoko
    Takahashi, Maiko
    Hayashida, Tetsu
    Kameyama, Kaori
    Kitagawa, Yuko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 701 - 708
  • [3] Prognostic implications of receptor discordance between primary and recurrent breast cancer
    Akiko Matsumoto
    Hiromitsu Jinno
    Takeshi Murata
    Tomoko Seki
    Maiko Takahashi
    Tetsu Hayashida
    Kaori Kameyama
    Yuko Kitagawa
    International Journal of Clinical Oncology, 2015, 20 : 701 - 708
  • [4] A meta-analysis of receptor status discordance between primary breast cancer and metastases
    Aurilio, Gaetano
    Disalvatore, Davide
    Bagnardi, Vincenzo
    Munzone, Elisabetta
    Adamoli, Laura
    Curigliano, Giuseppe
    Pruneri, Giancarlo
    Sciandivasci, Angela
    De Vita, Fernando
    Goldhirsch, Aron
    Nole, Franco
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Prognostic significance of TAZ expression in various cancers: a meta-analysis
    Feng, Juntao
    Ren, Pengwei
    Gou, Jinhai
    Li, Zhengyu
    ONCOTARGETS AND THERAPY, 2016, 9 : 5235 - 5244
  • [6] Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
    Liedtke, C.
    Broglio, K.
    Moulder, S.
    Hsu, L.
    Kau, S. -W.
    Symmans, W. F.
    Albarracin, C.
    Meric-Bernstam, F.
    Woodward, W.
    Theriault, R. L.
    Kiesel, L.
    Hortobagyi, G. N.
    Pusztai, L.
    Gonzalez-Angulo, A. M.
    ANNALS OF ONCOLOGY, 2009, 20 (12) : 1953 - 1958
  • [7] Incidence and prognostic significance of receptor discordance between primary breast cancer and paired bone metastases
    Lin, Mingxi
    Jin, Yizi
    Lv, Hong
    Hu, Xichun
    Zhang, Jian
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (07) : 1476 - 1489
  • [8] Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance
    Kotecha, Rupesh
    Tonse, Raees
    Rubens, Muni
    McDermott, Michael W.
    Odia, Yazmin
    Appel, Haley
    Mehta, Minesh P.
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [9] Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer
    Shiino, Sho
    Kinoshita, Takayuki
    Yoshida, Masayuki
    Jimbo, Kenjiro
    Asaga, Sota
    Takayama, Shin
    Tsuda, Hitoshi
    CLINICAL BREAST CANCER, 2016, 16 (04) : E133 - E140
  • [10] PATIENTS WITH DISCORDANCE IN ESTROGEN RECEPTOR BETWEEN PRIMARY BREAST CANCERS AND RECURRENT TUMORS HAVE POOR OUTCOMES
    Akiyoshi, Sayuri
    Koi, Yumiko
    Igawa, Akiko
    Saruwatari, Akihir
    Oikawa, Masahiro
    Koga, Chinami
    Nishimura, Sumiko
    Nakamura, Yoshiaki
    Ishida, Mayumi
    Ohno, Shinji
    BREAST, 2013, 22 : S55 - S55